Clorox Company (CLX) has been in spotlight due to major stock transactions, with entities like Toronto Dominion Bank and Barclays PLC adjusting their stock positions. Simultaneously, Nomura Asset Management Co. Ltd. and Quantinno Capital Management LP have increased their holdings. The stocks underperformed compared to competitors, but the Q3 earnings topped household products stocks. A groundbreaking partnership has been announced with M2030 to advance supply chain climate action. The company also rewarded its stakeholders with regular quarterly dividends of $1.22/share while demonstrating consistent performance making it a fascinating choice for dividend investment. The company hit a 52-week high and was upgraded to 'Buy'. Key board member appointments and a series of stock acquisitions by various capital and asset management companies added to the company's upward momentum. Despite some recommendations to 'reduce', most consensus leaned towards the company as a viable investment in household and personal care stocks. CLX effectively finished its divestiture of Better Health VMS business, and provided promising outlooks for FY25. Institutional ownership is rapidly increasing and the stock outpaced its Consumer Staples peers. The company has achieved significant recognition in safety and sustainability for its progressive efforts.
Clorox Company CLX News Analytics from Thu, 22 Feb 2024 08:00:00 GMT to Sat, 14 Dec 2024 11:49:33 GMT -
Rating 8
- Innovation 2
- Information 7
- Rumor 5
